相关实验视频

Updated: May 5, 2026

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

纠正"向卡特普辛的SARS-CoV-2抑制剂:设计,合成和生物活性"

Philipp Flury¹, Julian Breidenbach², Nadine Krüger³

¹Institute of Pharmacy, Pharmaceutical/Medicinal Chemistry and Tübingen Center for Academic Drug Discovery, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, Tübingen 72076, Germany.

ACS pharmacology & translational science

|April 18, 2024

概括

这项研究纠正了先前发表的DOI文章,确保科学文献的准确引用和引用. 它对于保持研究记录的完整性和促进正确的归因至关重要.

科学领域:

科学出版科研出版
学术传播学术交流

背景情况:

准确的引用对于科学完整性至关重要.
适当的引用确保了研究的可复制性和可追溯性.

研究的目的:

为特定的物品提供纠正DOI.
确保科学文献中的引用准确.

主要方法:

纠正该文章的DOI.

主要成果:

修正后的DOI现在可用了.
确保了文章的准确引用.

结论:

准确的DOI对于科学话语至关重要.
这次校正符合学术出版的标准.

更多相关视频

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...